Quinones for protection against radiation exposure
CA2912871A1
Carboxylic acid derivatives for treatment of oxidative stress disorders
WO2014145116A2
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
CA2883879A1
Quinone derivatives for use in the modulation of redox status of individuals
US2014275054A1
Resorufin derivatives for treatment of oxidative stress disorders
US2014275045A1
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
CA2842486A1
Methods for oxidation of alpha tocotrienol in the presence of non-alpha tocotrienols
WO2013006736A1
Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
WO2013006737A1
Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinones
EP2720689A1
Catechol derivatives for treatment of oxidative stress diseases
WO2012170773A1
Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
WO2012154613A1
Improved process for the preparation of d-alpha-tocotrienol from natural extracts
WO2012068552A1
Methods for improving blood glucose control
BR112013002877A2
treatment of mitochondrial diseases with naphthoquinones
CN105147651A
Formulations of quinones for the treatment of ophthalmic diseases
CA2795726A1
Treatment of ataxia telangiectasia
EP2519232A1
Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
CN102647981A
Methods for the prevention and treatment of cerebral ischemia
CA2759984A1
Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
BRPI0918139A2
composition, medicinal or functional food, dietary or dietary supplement for the treatment of pervasive developmental disorders with redox active therapies and use
